Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.59% | 50.13% | 216.18% | 422.28% | 363.08% |
| Total Depreciation and Amortization | 1.51% | 3.23% | 6.33% | 8.99% | 6.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 388.16% | 640.24% | -93.41% | -97.63% | -85.17% |
| Change in Net Operating Assets | -351.06% | -782.07% | -131.05% | 31.53% | 89.41% |
| Cash from Operations | 29.46% | 36.05% | 20.60% | 44.72% | 72.35% |
| Capital Expenditure | -17.53% | -9.22% | -36.78% | -42.67% | -11.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 91.45% | 95.70% | -2,524.88% | -1,386.88% | -1,386.88% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -892.71% | -395.96% | -277.03% | 267.21% | -87.07% |
| Cash from Investing | -66.55% | -73.99% | -34,983.89% | -101.65% | -239.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | 20.03% | 1.90% | -11.63% | -18.73% | 128.18% |
| Repurchase of Common Stock | -26.47% | -1.95% | 41.99% | -227.90% | 20.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.53% | -9.54% | 15.91% | 65.87% | 49.26% |
| Cash from Financing | 63.04% | 76.74% | 95.33% | -2,352.20% | -94.84% |
| Foreign Exchange rate Adjustments | -79.36% | -88.41% | 122.53% | 8,701.96% | 237.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.18% | 253.78% | -7.01% | -181.44% | -173.15% |